271 related articles for article (PubMed ID: 14734743)
21. 1,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteoblast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts.
Lee SK; Kalinowski J; Jastrzebski S; Lorenzo JA
J Immunol; 2002 Sep; 169(5):2374-80. PubMed ID: 12193704
[TBL] [Abstract][Full Text] [Related]
22. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
Burrell BE; Lu G; Li XC; Bishop DK
J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
[TBL] [Abstract][Full Text] [Related]
23. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
24. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.
Kon T; Cho TJ; Aizawa T; Yamazaki M; Nooh N; Graves D; Gerstenfeld LC; Einhorn TA
J Bone Miner Res; 2001 Jun; 16(6):1004-14. PubMed ID: 11393777
[TBL] [Abstract][Full Text] [Related]
25. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
Ikeda T; Utsuyama M; Hirokawa K
J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
[TBL] [Abstract][Full Text] [Related]
26. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig.
Guillot C; Ménoret S; Guillonneau C; Braudeau C; Castro MG; Lowenstein P; Anegon I
Blood; 2003 Apr; 101(8):3325-33. PubMed ID: 12515725
[TBL] [Abstract][Full Text] [Related]
27. A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response.
Seshasayee D; Wang H; Lee WP; Gribling P; Ross J; Van Bruggen N; Carano R; Grewal IS
J Biol Chem; 2004 Jul; 279(29):30202-9. PubMed ID: 15145935
[TBL] [Abstract][Full Text] [Related]
28. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
Khapli SM; Mangashetti LS; Yogesha SD; Wani MR
J Immunol; 2003 Jul; 171(1):142-51. PubMed ID: 12816992
[TBL] [Abstract][Full Text] [Related]
29. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint.
Haynes DR; Crotti TN; Loric M; Bain GI; Atkins GJ; Findlay DM
Rheumatology (Oxford); 2001 Jun; 40(6):623-30. PubMed ID: 11426018
[TBL] [Abstract][Full Text] [Related]
30. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
[TBL] [Abstract][Full Text] [Related]
31. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
[TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand.
Min JK; Kim YM; Kim YM; Kim EC; Gho YS; Kang IJ; Lee SY; Kong YY; Kwon YG
J Biol Chem; 2003 Oct; 278(41):39548-57. PubMed ID: 12893832
[TBL] [Abstract][Full Text] [Related]
33. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function.
Wong BR; Josien R; Choi Y
J Leukoc Biol; 1999 Jun; 65(6):715-24. PubMed ID: 10380891
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
35. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction.
Cremer I; Dieu-Nosjean MC; Maréchal S; Dezutter-Dambuyant C; Goddard S; Adams D; Winter N; Menetrier-Caux C; Sautès-Fridman C; Fridman WH; Mueller CG
Blood; 2002 Nov; 100(10):3646-55. PubMed ID: 12393586
[TBL] [Abstract][Full Text] [Related]
36. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
Corbascio M; Mahanty H; Osterholm C; Qi Z; Pearson TC; Larsen CP; Freise CE; Ekberg H
Transplantation; 2002 Jul; 74(1):35-41. PubMed ID: 12134096
[TBL] [Abstract][Full Text] [Related]
37. Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells.
Nathan MJ; Mold JE; Wood SC; Csencsits K; Lu G; Eichwald EJ; Bishop DK
J Immunol; 2004 Jun; 172(11):6626-33. PubMed ID: 15153477
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.
Pearse RN; Sordillo EM; Yaccoby S; Wong BR; Liau DF; Colman N; Michaeli J; Epstein J; Choi Y
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11581-6. PubMed ID: 11562486
[TBL] [Abstract][Full Text] [Related]
39. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
40. IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
Mangashetti LS; Khapli SM; Wani MR
J Immunol; 2005 Jul; 175(2):917-25. PubMed ID: 16002690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
